Ahead of opioid trial, Johnson & Johnson settles with Ohio counties for $20 million

A Johnson & Johnson sign.
(Image credit: Mario Tama/Getty Images)

Johnson & Johnson has reached a $20.4 million settlement with two counties in Ohio, in order to avoid being part of a major opioid trial slated to start in Cleveland later this month.

Under the terms of the settlement, Cuyahoga and Summit counties will receive $10 million in cash, $5 million as reimbursement for legal fees, and $5.4 million for opioid-related nonprofits. The deal does not include an admission of liability. In a statement Tuesday night, Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals, said the company "recognizes the opioid crisis is a complex public health challenge and is working collaboratively to help communities and people in need."

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Explore More
Catherine Garcia, The Week US

Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.